Patents by Inventor Omid Safa Jamilabadi

Omid Safa Jamilabadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thrombotic episode risk assays using oxidized phospholipids
    Patent number: 7011956
    Abstract: An assay to assess thrombotic risk in which oxidized lipids comprising phospholipids are utilized as a membrane source in a clotting assay and the results compared to an assay in which unoxidized phospholipid is used as a membrane source in the presence and absence of activated protein C (“APC”). The assay can monitor for the presence of antibodies in the patient which interfere specifically with the anticoagulant function of APC in an oxidation dependent or independent manner. This can indicate the propensity of the patient to experience episodes of vein thrombosis or arterial thrombosis.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: March 14, 2006
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Naomi L. Esmon, Omid Safa Jamilabadi